Dominari Holdings Inc. financial data

Symbol
DOMH on Nasdaq
Industry
Security Brokers, Dealers & Flotation Companies
Location
725 Fifth Avenue, 22 Nd Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
Aikido Pharma Inc. (to 12/21/2022), AIkido Pharma Inc. (to 12/21/2022), SPHERIX INC (to 3/13/2020), BIOSPHERICS INC (to 3/21/2001)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.33K % -43.6%
Debt-to-equity 10.3 % +83.6%
Return On Equity -43.8 % -20.9%
Return On Assets -39.7 % -15.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.28M shares +17.4%
Common Stock, Shares, Outstanding 6.24M shares +18.1%
Entity Public Float 12.1M USD -60.7%
Common Stock, Value, Issued 9K USD 0%
Weighted Average Number of Shares Outstanding, Basic 6.06M shares +25.6%
Weighted Average Number of Shares Outstanding, Diluted 6.06M shares +25.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 6.17M USD +8596%
Research and Development Expense 2K USD -94.4%
General and Administrative Expense 24M USD -1.87%
Operating Income (Loss) -14.5M USD +31.3%
Nonoperating Income (Expense) -7.53M USD -55.8%
Net Income (Loss) Attributable to Parent -22M USD +15.1%
Earnings Per Share, Basic -3.8 USD/shares +23.7%
Earnings Per Share, Diluted -3.37 USD/shares +32.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.8M USD +61.3%
Marketable Securities, Current 6.32M USD -69.4%
Cash, Cash Equivalents, and Short-term Investments 13K USD
Assets, Current 28.8M USD -25.1%
Other Long-term Investments 20.9M USD
Property, Plant and Equipment, Net 291K USD -24.8%
Operating Lease, Right-of-Use Asset 3.15M USD -10.9%
Assets 49.1M USD -27.5%
Employee-related Liabilities, Current 177K USD -86.8%
Liabilities, Current 3.9M USD +46.7%
Operating Lease, Liability, Noncurrent 2.82M USD
Liabilities 6.71M USD +13.5%
Retained Earnings (Accumulated Deficit) -220M USD -11.1%
Stockholders' Equity Attributable to Parent 42.4M USD -31.4%
Liabilities and Equity 49.1M USD -27.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.59M USD -115%
Net Cash Provided by (Used in) Financing Activities -939K USD -105%
Net Cash Provided by (Used in) Investing Activities 7.72M USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 6.3M shares +17.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -23.6M USD -566%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.8M USD +61.3%
Deferred Tax Assets, Valuation Allowance 55.9M USD +13.9%
Deferred Tax Assets, Gross 57.2M USD +15.6%
Operating Lease, Liability 3.24M USD
Depreciation 26K USD +271%
Payments to Acquire Property, Plant, and Equipment 361K USD
Lessee, Operating Lease, Liability, to be Paid 4.35M USD -14.2%
Property, Plant and Equipment, Gross 427K USD
Operating Lease, Liability, Current 429K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 685K USD -0.44%
Lessee, Operating Lease, Liability, to be Paid, Year One 685K USD -8.67%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.11M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 685K USD -0.44%
Deferred Tax Assets, Operating Loss Carryforwards 33.1M USD +26.2%
Preferred Stock, Shares Authorized 50M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 766K USD +11.3%
Operating Lease, Payments 187K USD +450%
Additional Paid in Capital 263M USD +1%
Deferred Tax Assets, Net of Valuation Allowance 1.22M USD +272%
Share-based Payment Arrangement, Expense 100K USD -98%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%